| Document Type
|
:
|
BL
|
| Record Number
|
:
|
859926
|
| Title & Author
|
:
|
Congenital hyperinsulinism : : a practical guide to diagnosis and management /\ Diva D. De León-Crutchlow, Charles A. Stanley, editors.
|
| Publication Statement
|
:
|
Cham, Switzerland :: Humana Press,, [2019]
|
| Series Statement
|
:
|
Contemporary endocrinology
|
| Page. NO
|
:
|
1 online resource
|
| ISBN
|
:
|
3030029611
|
|
|
:
|
: 9783030029616
|
|
|
:
|
3030029603
|
|
|
:
|
9783030029609
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Intro; Series Editor Foreword; Preface; Contents; Contributors; Chapter 1: Approach to the Diagnosis of Neonates and Infants with Persistent Hypoglycemia; Introduction; Diagnosis of HI: Fasting Test and "Critical Samples"; Diagnosis of Hyperinsulinism Using the Closely Monitored Fasting Test; Diagnosis of Hyperinsulinism Based on a Random "Critical Sample"; Other Tests Used to Define Specific Phenotypes of Hyperinsulinism; Oral Protein Tolerance Test (oPTT); Oral Glucose Tolerance Test (oGTT); Acute Insulin Response (AIR) Tests; Genetic Testing in Neonates and Children with Hyperinsulinism
|
|
|
:
|
Chapter 4: Syndromic Causes of Congenital HyperinsulinismBeckwith-Wiedemann Syndrome; Kabuki Syndrome; Sotos Syndrome; Turner Syndrome; References; Chapter 5: Molecular Diagnosis of Congenital Hyperinsulinism; Genetic Heterogeneity of Congenital Hyperinsulinism (HI); Strategies for Genetic Screening; Interpretation of Genetic Test Results; Cascade Family Testing; Negative Genetic Test Results; Factors to Consider when Choosing Where to Send Samples for Genetic Testing; Conclusions; References; Chapter 6: Medical Management of Hyperinsulinism; Introduction
|
|
|
:
|
Diazoxide-Unresponsive HI due to Recessive KATP Channel MutationsDiazoxide-Unresponsive HI due to Dominant KATP Channel Mutations; Clinical Features and Management; Focal KATP Hyperinsulinism; Biallelic Recessive Diazoxide-Unresponsive KATPHI; Dominant Diazoxide-Unresponsive KATPHI; Dominant Diazoxide-Responsive KATPHI; Complications; Glucokinase Hyperinsulinism; Pathophysiology; Activating GCK Mutations; Clinical Features and Management; Dietary Treatment; Medical Treatment; Surgery; Diazoxide-Unresponsive HI with Unknown Genetics; Conclusions; References
|
|
|
:
|
Important Mimickers to Exclude in the Diagnosis of HyperinsulinismMultiple Pituitary Hormone Deficiencies in Neonates; AKT2; Autoimmune Hypoglycemia; Surreptitious Insulin Administration; Insulin Secretagogues; Insulinoma; Signs and Symptoms of Hyperinsulinism in Neonates and Children (See Table 1.5); Neonates; Infants and Children; Fasting Test to Evaluate Efficacy of Treatment ("Safety Fast" and "Cure Fast"); Conclusion; References; Chapter 2: Diazoxide-Responsive Forms of Congenital Hyperinsulinism; Introduction; Definition of Diazoxide Responsiveness
|
|
|
:
|
Perinatal Stress-Induced HyperinsulinismGlutamate Dehydrogenase Hyperinsulinism (Hyperinsulinism/Hyperammonemia Syndrome); HNF4A and HNF1A Hyperinsulinism; Rarer Forms of Diazoxide-Responsive Hyperinsulinism; Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase Hyperinsulinism; Uncoupling Protein 2 Hyperinsulinism; Monocarboxylate Transport Protein 1 Hyperinsulinism; Additional Rare Forms of Diazoxide-Responsive Hyperinsulinism; References; Chapter 3: Diazoxide-Unresponsive Forms of Congenital Hyperinsulinism; Introduction; KATP Hyperinsulinism; Pathophysiology
|
| Abstract
|
:
|
This unique book is a practical guide for the clinician faced with the challenge of diagnosing and managing neonates, infants and children with congenital hyperinsulinism (HI), within the framework of pathophysiology and molecular genetics. Major advances have been made in HI research over the past two decades, and with this better understanding of the molecular genetics of HI, a "personalized" approach to management according to the type of hyperinsulinism, and particularly according to the likelihood of focal hyperinsulinism, is starting to emerge. The opening chapter discusses HI diagnosis using biochemical approaches and phenotype characterization. The various forms of HI are then presented in detail in three main categories: diazoxide-responsive, diazoxide-unresponsive and syndromic HI. Both medical and surgical management strategies are then discussed, covering imaging, histology, surgical approach, and post-operative management. Complications, such as feeding problems, and long-term outcomes, such as neurodevelopmental issues, are carefully considered in the final chapter. Practical and user-friendly, Congenital Hyperinsulinism is the go-to resource for pediatric endocrinologists, residents and fellows, general pediatricians and neonatologists.
|
| Subject
|
:
|
Diabetes in children.
|
| Subject
|
:
|
Diabetes-- Molecular aspects.
|
| Subject
|
:
|
Insulin-- Secretion.
|
| Subject
|
:
|
Diabetes in children.
|
| Subject
|
:
|
Diabetes-- Molecular aspects.
|
| Subject
|
:
|
Insulin-- Secretion.
|
| Subject
|
:
|
MEDICAL-- Physiology.
|
| Subject
|
:
|
SCIENCE-- Life Sciences-- Human Anatomy Physiology.
|
| Dewey Classification
|
:
|
612.34
|
| LC Classification
|
:
|
QP572.I5
|
| Added Entry
|
:
|
De León-Crutchlow, Diva D.
|
|
|
:
|
Stanley, Charles A.
|